Adenolymphoma
Showing 1 - 14 of 14
Pleomorphic Adenoma of the Parotid, Warthin Tumor, Head and Neck Disorder Trial in Palo Alto (Fluorescein Sodium)
Not yet recruiting
- Pleomorphic Adenoma of the Parotid
- +2 more
- Fluorescein Sodium
-
Palo Alto, CaliforniaStanford Medical Center
Sep 19, 2023
Radiofrequency Ablation Trial (Ultrasound-guided Radiofrequency Ablation of Parotid Warthin's Tumor)
Not yet recruiting
- Radiofrequency Ablation
- Ultrasound-guided Radiofrequency Ablation of Parotid Warthin's Tumor
- (no location specified)
Oct 4, 2021
Warthin's Tumor of Parotid Gland Trial in Assiut (Ultrasound-Guided Ethanol Sclerotherapy (UGES))
Recruiting
- Warthin's Tumor of Parotid Gland
- Ultrasound-Guided Ethanol Sclerotherapy (UGES)
-
Assiut, EgyptAssiut university
Jan 23, 2022
Cardiovascular Disease Trial in Worldwide (Dalcetrapib, Placebo)
Terminated
- Cardiovascular Disease
- Dalcetrapib
- Placebo
-
Los Angeles, California
- +109 more
Mar 20, 2020
Type 2 Diabetes Trial (Sitagliptin, Placebo)
Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (dimethyl fumarate, Placebo)
Completed
- Relapsing-Remitting Multiple Sclerosis
- dimethyl fumarate
- Placebo
-
Birmingham, Alabama
- +245 more
Dec 7, 2020
Peripheral Artery Disease Trial in Worldwide (Rivaroxaban (Xarelto, BAY59-7939), Rivaroxaban-Placebo)
Completed
- Peripheral Artery Disease
- Rivaroxaban (Xarelto, BAY59-7939)
- Rivaroxaban-Placebo
-
Alexander City, Alabama
- +532 more
Dec 7, 2020
Lymphoma, Non-Hodgkin Trial in Worldwide (Venetoclax, Cyclophosphamide, Obinutuzumab)
Moderate Risk of CVD Trial in Worldwide (Aspirin (Acetylsalicylic acid, BAYE4465), Placebo)
Completed
- Moderate Risk of CVD
- Aspirin (Acetylsalicylic acid, BAYE4465)
- Placebo
-
Birmingham, Alabama
- +465 more
Sep 26, 2018
Diabetes, Type 2, Cardiovascular Diseases, Risk Factors Trial in Worldwide (Placebo, Canagliflozin (JNJ-28431754) 100 mg,
Completed
- Diabetes Mellitus, Type 2
- +2 more
- Placebo
- +2 more
-
Birmingham, Alabama
- +312 more
Nov 5, 2018
Myocardial Infarction, Cardiovascular Death, Atherothrombosis Trial in Worldwide (Ticagrelor 90 mg, Ticagrelor 60 mg, Ticagrelor
Completed
- Myocardial Infarction
- +3 more
- Ticagrelor 90 mg
- +2 more
-
Alexander City, Alabama
- +846 more
Dec 18, 2015